NEW VISITOR POLICY in effect as of Monday, March 30
See all Novel Coronavirus Information for Penn Medicine Patients
Adults (18-65), Geriatrics (65+)
There is no publicly available rating for this medical professional for one of the following reasons:
Adults (18-65), Geriatrics (65+)
My clinical expertise is in Molecular Pathology.
Hospital of the University of Pennsylvania
3400 Spruce Street
Philadelphia, PA 19104
A facility of the Hospital of the University of Pennsylvania
Brown JT, Beldorth IJ, Laosinchai-Wolf W, Fahey ME, Jefferson KL, Ruskin AK, Roth JJ, Cai L, Watt CD, Press RD, Yang F, Hedges JB, and Andruss BF: Analytical validation of a highly sensitive, multiplexed chronic myeloid leukemia monitoring system targeting BCR-ABL1 RNA. The Journal of Molecular Diagnostics 21 (4): 718-733,2019.
McMahon C, Ferng T, Canaani J, Wang E, Morrissette J, Eastburn D, Pellegrino M, Durruthy-Durruthy R, Watt CD, Asthana S, Lasater E, DeFilippis RA, Peretz C, McGary L, Deihimi S, Logan A, Luger S, Shah N, Carroll M, Smith C, and Perl A: Clonal selection with Ras pathway activation mediates secondary clinical resistance to selective FLT3 inhibition in acute myeloid leukemia. Cancer Discovery : epub,2019.
Nasrallah MP, Binder ZA, Oldridge DA, Zhao J, Lieberman DB, Roth JJ, Watt CD, Sukhadia S, Klinman E, Daber RD, Desai A, O’Rourke DM, and Morrissette JJD: Molecular neuropathology in practice: Clinical profiling and integrative analysis of molecular alterations in glioblastoma. Academic Pathology 6 : epub,2019.
McMahon CM, Canaani J, Rea B, Sargent R, Watt CD, Morrissette JJD, Carroll M, and Perl AE: Gilteritinib induces differentiation in relapsed and refractory FLT3-mutated acute myeloid leukemia. Blood Advances 3 (10): 1581-1585,2019.
Nelson W, Bagley S, Watt CD, and Nasrallah M: An institutional experience with pyrosequencing for MGMT promoter methylation analysis. Modern Pathology 32 (supplement 2): 29,2019.
Herlihy SE, Carlin A, Nasrallah NP, Watt CD and Van Deerlin VM: Evaluation of a Targeted Realtime Assay for Rapid Identification of IDH1 and IDH2 Disease-Associated Variants in Brain Tumors The Journal of Molecular Diagnostics : 2019.
Garces S, Nelson N, Watt CD, and Priore S: FLT3 Variants Near Codon 835: An Institutional Experience Comparing Rapid Restriction Digest Testing with Massively Parallel Sequencing. The Journal of Molecular Diagnostics : 2019.
Belman J, Gentile C, Lake JI, Roth JJ and Watt CD: Optimizing RNA extraction to facilitate BCR/ABL1 quantitative testing. The Journal of Molecular Diagnostics 20 (6): 1031,2018.
Bhattacharyya S, Castro-Echeverry E, Kelly LM, Burnes CL, Gentile C, Roy S, Nikiforova M, Watt CD and Aggarwal N: Standardization of FLT3-ITD mutation allelic ratio reporting in the clinical laboratory setting. The Journal of Molecular Diagnostics 20 (6): 920,2018.
Rathore S, Bakas S, Nasrallah MP, Bagley SJ, Akbari H, Ha SM, Mamourian EC, Watt CD, and Davatzikos C: Non-invasive determination of the O6-methylguanine-DNA-methyltransferase (MGMT) promoter methylation status in glioblastoma (GBM) using magnetic resonance imaging (MRI). Journal of Clinical Oncology 36 (suppl): 2018.
Department of Pathology and Laboratory Medicine Hospital of the University of Pennsylvania3400 Spruce Street